Patent term adjustment, or PTA, adds time to certain U.S. patents when qualifying USPTO delays reduce the effective patent term. Reviewing the calculation can reveal missed agency delay, incorrect applicant-delay deductions, or overlap errors that affect a patent's expiration date.
Key Takeaways
- PTA compensates eligible utility and plant patents for specified USPTO prosecution delays.
- The basic calculation adds A, B, and C delay, then subtracts overlapping periods and applicant delay.
- Late, supplemental, incomplete, and post-allowance filings can reduce the available adjustment.
- An RCE generally affects B delay, but it does not necessarily eliminate every form of PTA.
- A terminal disclaimer can prevent PTA from extending a patent beyond the disclaimed date.
- Patent owners should compare the USPTO determination with the complete prosecution history promptly after issuance.
What Is Patent Term Adjustment?
Patent term adjustment is additional patent life awarded under 35 U.S.C. Section 154(b) for certain delays attributable to the USPTO. It generally applies to qualifying original utility and plant patents, not design or reissue patents. The USPTO calculates the adjustment in days and states its determination when the patent issues.
PTA is separate from the patent's standard term. A utility patent generally has a term of 20 years measured from the applicable filing date, often the earliest effective nonprovisional U.S. filing date. Priority claims, international applications, terminal disclaimers, maintenance fees, and other events can affect the practical expiration analysis. For broader background on patent duration and enforceability, see this overview of U.S. patent law.
The purpose of PTA is to prevent specified examination delays from consuming too much of that standard term. It does not compensate for every day an application remains pending. Only delays recognized by the statute and USPTO rules count, and the calculation must account for delays attributable to the applicant.
PTA can matter even when the adjustment appears modest. An added period at the end of a commercially significant patent may affect licensing, product launch planning, infringement exposure, and settlement value. You should therefore treat the USPTO's number as a determination to verify, not merely a number to copy into a portfolio database.
How USPTO PTA Uses A, B, and C Delays
The USPTO organizes qualifying agency delay into three categories commonly called A delay, B delay, and C delay. Each category addresses a different prosecution problem.
| Category | General Trigger | Calculation Treatment |
|---|---|---|
| A delay | The USPTO misses specified response or processing periods, including the initial 14-month period and certain four-month periods. | Add qualifying days. |
| B delay | The patent does not issue within three years, subject to statutory exclusions. | Add qualifying days after the three-year point. |
| C delay | Issuance is delayed by specified proceedings, secrecy orders, or successful appellate review. | Add qualifying days. |
| Overlap | The same calendar day qualifies under more than one delay category. | Subtract duplicate days. |
| Applicant delay | The applicant does not make reasonable efforts to conclude prosecution. | Subtract chargeable days. |
A delay includes situations in which the USPTO does not provide an initial qualifying action within 14 months, does not act within four months after an applicant's reply, does not act within four months after certain appeal or court decisions, or does not issue the patent within four months after payment of the issue fee.
B delay concerns pendency beyond three years, but the calculation excludes specified periods. These can include time consumed by continued examination, appellate review, certain proceedings, secrecy orders, and applicant-requested delay. C delay addresses specified interference or derivation proceedings, secrecy orders, and qualifying appellate review that reverses an adverse patentability determination. Because the categories can cover the same dates, PTA rules prohibit counting one calendar day twice.
Calculating Patent Term Adjustment Step by Step
The basic PTA formula is straightforward, but classifying each day can be difficult:
PTA = A delay + B delay + C delay - overlapping delay - applicant delay
Start with the application's official filing and prosecution dates. Identify each deadline the USPTO was required to meet, then count the delay after that deadline through the qualifying agency action. Separately calculate eligible B and C periods. Next, mark dates appearing in more than one category so they are counted only once. Finally, identify applicant-delay periods under the rules. The resulting PTA cannot be negative.
Consider this hypothetical example. These dates and figures are illustrative, not a substitute for calculating from your own USPTO record:
- The first qualifying action was due May 1, 2022, but mailed May 21, producing 20 days of A delay.
- A later USPTO response was due January 10, 2023, but mailed January 25, adding 15 days of A delay.
- After accounting for excluded periods, the application accumulated 30 days of B delay.
- A qualifying appellate event produced 10 days of C delay.
- Twelve calendar days overlapped between categories, and the record showed 18 days of applicant delay.
The arithmetic would be 35 A days plus 30 B days plus 10 C days, minus 12 overlap days and 18 applicant-delay days. The hypothetical PTA would be 45 days.
A spreadsheet or patent term adjustment calculator can help organize dates, but it cannot decide every classification issue. Confirm the legal treatment of RCE periods, supplemental papers, appeal events, and other unusual entries before relying on an automated result.
Patent Term Adjustment Applicant Delay
Applicant delay reduces PTA when the applicant fails to make reasonable efforts to conclude prosecution. A common example is taking more than three months to reply to a USPTO notice or office action. The deduction can apply even when the applicant obtained an extension and filed within the extended response period.
Other actions that may create applicant delay include filing an incomplete reply, submitting an unsolicited supplemental response, filing certain papers after a notice of allowance, or submitting a preliminary amendment shortly before an office action when the filing requires another action. Delay may also arise from failing to correct an omission or to address abandonment promptly.
Information disclosure statements require particular care. An IDS filed after another response may produce a deduction in some circumstances, even if the cited information did not actually delay the examiner. A certification under the applicable USPTO rule can protect against certain deductions when cited information was recently received from a patent office or another qualifying source. The facts and timing must satisfy the current rule.
To preserve potential PTA, use a prosecution docket that tracks both the formal response deadline and the three-month PTA date. Submit complete responses, coordinate foreign references quickly, and avoid unnecessary supplemental filings. Strategic speed is not always the only goal, however. Claim scope and patentability may be worth more than additional days at the end of the term. Applicants pursuing technical inventions should coordinate PTA decisions with their broader engineering patent strategy.
How RCEs and Terminal Disclaimers Affect PTA
A request for continued examination, or RCE, requires special review because time consumed by continued examination is excluded from B delay. Under the governing treatment, the relevant excluded period generally runs from the filing of the RCE until the notice of allowance. The application may still earn qualifying A or C delay, so filing an RCE does not automatically reduce total PTA to zero.
Post-RCE filings can create separate issues. An amendment, supplemental response, or IDS filed after the RCE may be treated as applicant delay depending on its timing and whether an exception applies. Review each post-RCE entry rather than assuming all time after the RCE belongs to the USPTO or the applicant.
A terminal disclaimer affects the end date differently. Patent term adjustment generally cannot extend a patent beyond the expiration date specified in the disclaimer. As a result, a patent may show a positive PTA calculation while receiving no practical benefit beyond the disclaimed date. The exact disclaimer language and the referenced patent's term must be reviewed.
These decisions involve tradeoffs. An RCE may advance prosecution, while an appeal may preserve a different portion of potential B delay. A terminal disclaimer may address an obviousness-type double patenting issue but shorten the commercially useful term. Before choosing based only on PTA, evaluate claim scope, family relationships, expected product life, prosecution cost, and enforceability. Those factors can later affect licensing and patent infringement analysis.
How to Review the USPTO PTA Determination
The USPTO provides its PTA determination with the issue notification and prints the adjustment on the issued patent. To verify it, obtain the complete application history and build a chronological ledger. Record the filing date, every office communication, each applicant response, appeal activity, RCE filings, the notice of allowance, issue-fee payment, and the patent's issue date.
Compare the agency's A, B, and C totals with your independent counts. For A delay, check whether the USPTO used the correct starting and ending events. For B delay, confirm that excluded periods were measured correctly. For C delay, verify that the proceeding or review satisfies the statutory conditions. Then check whether overlap was subtracted once and whether each applicant-delay entry corresponds to an applicable rule.
You can review electronic application records through the USPTO's Patent Center. USPTO datasets available through data.uspto.gov may also support portfolio-level review, but the official application record remains essential for resolving a patent-specific date or filing dispute. For detailed applicant-delay rules, consult the USPTO's current Manual of Patent Examining Procedure guidance.
Flag discrepancies involving an unexplained applicant deduction, an omitted agency response period, an overlap counted more than once, or incorrect treatment of an RCE. Also check for a terminal disclaimer before converting the stated PTA into an expected expiration date.
If the USPTO determination appears inconsistent with the record, applicant delay or overlap is disputed, or an RCE or terminal disclaimer complicates the result, you can post your legal need on UpCounsel's marketplace. A patent attorney can audit the application history, recalculate the adjustment, assess the effect of relevant filings, and prepare an appropriate challenge if warranted. Responses typically arrive within a day.
Challenging an Incorrect PTA Calculation
An applicant that disagrees with the USPTO's PTA determination may request reconsideration. The ordinary deadline is two months after the patent issues. USPTO rules allow extensions for this request in specified circumstances, but a different pre-issuance procedure applies to certain requests seeking reinstatement of days deducted for taking more than three months to reply. Check the current USPTO instructions immediately because the available remedy depends on the type of alleged error.
A persuasive request should identify the exact disputed dates, applicable delay category, USPTO action or applicant filing, and corrected arithmetic. Attach or cite the relevant prosecution entries. Do not merely assert that examination took too long. Explain why the statute and rules classify the period differently from the USPTO's calculation.
If the USPTO denies reconsideration, judicial review may be available through a civil action in the U.S. District Court for the Eastern District of Virginia. The governing statute provides a 180-day period following the Director's decision on reconsideration. Litigation requires careful evaluation of jurisdiction, timing, administrative exhaustion, potential term value, and cost. Current procedural rules should be confirmed before filing.
Preserve the issue by downloading the application record, saving the issue notification, and documenting your calculation. If the disputed term has substantial commercial value, consider how a challenge may affect licensing, enforcement, and pending disputes. A broader patent litigation strategy may be necessary when the expiration date affects an active or expected case.
PTA vs. Patent Term Extension and Patent Expiration
Patent term adjustment and patent term extension address different delays. PTA under 35 U.S.C. Section 154(b) concerns qualifying delays during USPTO examination. Patent term extension under 35 U.S.C. Section 156 generally concerns regulatory review of certain patented products, including qualifying drugs and medical devices. A patent may require analysis under both systems, but the eligibility rules and calculations are separate.
To estimate when a patent expires, begin with its standard statutory term. For many modern utility and plant patents, that means 20 years from the applicable filing date. Then examine PTA, any available patent term extension, terminal disclaimers, and other term-specific events. A utility patent can also lapse before its scheduled expiration if required maintenance fees are not paid, although reinstatement may be available in qualifying circumstances.
Design patents follow a different term system and do not receive PTA. Design patents based on applications filed on or after May 13, 2015, generally have a 15-year term measured from issuance. Older patents and applications can be governed by earlier rules, so do not apply the modern 20-year or 15-year framework without checking the relevant dates.
Expiration also differs from validity. A patent may remain within its stated term but have claims held invalid or disclaimed. Conversely, expiration does not erase past infringement claims that may still be timely. For a business decision, calculate the expected end date and separately evaluate claim status, ownership, maintenance fees, enforceability, and relevant litigation history.
Frequently Asked Questions
What Is Patent Term Adjustment?
Patent term adjustment is extra time added to an eligible U.S. patent for specified USPTO delays during examination. The adjustment is measured in days and attaches at the end of the patent's otherwise applicable term. It is not guaranteed merely because prosecution was lengthy, since statutory exclusions, overlapping delay, and applicant conduct can reduce the award.
When Does a Patent Expire?
A patent expires when its governing statutory term ends, as modified by any applicable adjustment, extension, or disclaimer. The practical date may also depend on the correct filing-date chain and payment of maintenance fees. Because the date printed or estimated from a filing alone may be incomplete, review the patent family and USPTO records before relying on an expiration date.
How Long Does a Patent Last?
A modern U.S. utility patent generally lasts 20 years from the applicable filing date, while a qualifying modern design patent generally lasts 15 years from issuance. Actual enforceable life can be shorter because examination occurs before issuance, or because of maintenance-fee lapse, disclaimer, or invalidity. PTA may add time to eligible utility and plant patents.
How Do You Calculate PTA?
Calculate PTA by totaling qualifying A, B, and C delay, removing duplicate calendar days, and subtracting chargeable applicant delay. Use the dates in the official prosecution record rather than relying only on elapsed pendency. Review special events individually, including appeals, RCEs, supplemental papers, abandonment, and post-allowance filings, because each can change the classification of particular days.
How Long Are Patents Good for in the United States?
U.S. patent duration depends on the patent type and the law applicable to its filing date. Utility and plant patents usually use a filing-based term, while design patents use an issuance-based term. Older patents can follow transitional rules. A patent's commercial life may also end early if claims are canceled, disclaimed, held invalid, or allowed to lapse.
How Does a Terminal Disclaimer Affect Patent Term Adjustment?
A terminal disclaimer generally prevents PTA from carrying the patent beyond the expiration date stated in the disclaimer. The patent can still display an adjustment, but some or all of those additional days may provide no later expiration date. Review the executed disclaimer, referenced patent, priority relationship, and ownership requirements before determining the practical result.
